Capital Fund Management (CFM)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.6M Sell
84,367
-90,011
-52% -$6.14M 0.03% 783
2026
Q1
$11.3M Sell
174,378
-45,201
-21% -$3.19M 0.05% 502
2025
Q4
$14.8M Buy
219,579
+6,838
+3% +$460K 0.04% 630
2025
Q3
$15.6M Buy
212,741
+104,830
+97% +$6.96M 0.04% 625
2025
Q2
$5.61M Buy
+107,911
New +$6.14M 0.02% 1072
2025
Q1
– Sell
-23,386
Closed -$1.12M – 2142
2024
Q4
$1.12M Buy
+23,386
New +$1.2M ﹤0.01% 1724
2024
Q2
– Sell
-59,552
Closed -$2.42M – 1992
2024
Q1
$2.42M Buy
59,552
+18,551
+45% +$695K 0.01% 1357
2023
Q4
$1.52M Buy
41,001
+26,809
+189% +$1.01M ﹤0.01% 1661
2023
Q3
$542K Buy
+14,192
New +$581K ﹤0.01% 1785
2016
Q4
– Sell
-205,062
Closed -$2.48M – 1739
2016
Q3
$2.48M Buy
+205,062
New +$2.1M 0.02% 683
2016
Q2
– Sell
-61,966
Closed -$587K – 1619
2016
Q1
$587K Sell
61,966
-191,097
-76% -$1.8M 0.01% 1074
2015
Q4
$4.39M Sell
253,063
-60,168
-19% -$959K 0.05% 469
2015
Q3
$4.21M Buy
+313,231
New +$6.29M 0.05% 435
2013
Q3
– Sell
-18,800
Closed -$149K – 1697
2013
Q2
$149K Buy
+18,800
New +$120K ﹤0.01% 1259

Other funds holding HALO

Capital Fund Management (CFM)'s HALO Position: Q2 2026 in Review

Capital Fund Management (CFM) reduced its Halozyme (HALO) stake by 52% in Q2 2026, selling an estimated $6.14M and leaving 84,367 shares worth $6.6M. The position accounts for 0.03% of the portfolio, ranked #783.

Capital Fund Management (CFM) first reported a position in HALO in Q2 2013 and has held it in 14 quarters since. The position peaked at $15.6M in Q3 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Capital Fund Management (CFM) held 84,367 shares of Halozyme worth $6.6M as of Q2 2026.
  • Capital Fund Management (CFM) sold 90,011 Halozyme shares in Q2 2026, an estimated $6.14M.
  • Halozyme made up 0.03% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #783 holding.
  • Capital Fund Management (CFM) first reported a position in Halozyme in Q2 2013 and has held it in 14 quarters since.
  • Capital Fund Management (CFM)'s Halozyme position peaked at $15.6M in Q3 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.